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Corrigendum to: PD98059 and U0126 activate AMP-activated
protein kinase by increasing the cellular AMP:ATP ratio and not
via inhibition of the MAP kinase pathway (FEBS 29123)
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Available online 12 February 2005It should be noted that AMPK and U0126 inhibit insulin-stimulated 2-deoxyglucose uptake by diﬀerent mechanisms.AMPK
inhibits the translocation of GLUT4 to the plasma membrane [24] and U0126 inhibition only occurs after functional insertion of
GLUT4 into the plasma membrane.q DOI of original article: 10.1016/j.febslet.2004.11.084.
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